Kriti Nutrients Ltd
Incorporated in 1992, Kriti Nutrients Ltd is in the business of Soya Seed Extraction and Manufacturing & Selling of cooking oil[1]
- Market Cap ₹ 342 Cr.
- Current Price ₹ 68.3
- High / Low ₹ 125 / 63.6
- Stock P/E 10.5
- Book Value ₹ 45.6
- Dividend Yield 0.44 %
- ROCE 24.5 %
- ROE 18.7 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 7.13% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 288 | 310 | 358 | 456 | 461 | 485 | 520 | 690 | 753 | 797 | 684 | 734 | 866 | |
| 276 | 296 | 343 | 442 | 429 | 454 | 496 | 668 | 733 | 766 | 622 | 686 | 826 | |
| Operating Profit | 12 | 14 | 15 | 14 | 31 | 31 | 24 | 22 | 19 | 31 | 62 | 48 | 40 |
| OPM % | 4% | 5% | 4% | 3% | 7% | 6% | 5% | 3% | 3% | 4% | 9% | 7% | 5% |
| 1 | 2 | 1 | 3 | 2 | 1 | 3 | 2 | 3 | 4 | 4 | 8 | 8 | |
| Interest | 5 | 5 | 5 | 5 | 5 | 2 | 2 | 1 | 2 | 4 | 1 | 1 | 1 |
| Depreciation | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 6 |
| Profit before tax | 6 | 9 | 9 | 10 | 25 | 27 | 22 | 20 | 17 | 28 | 61 | 50 | 42 |
| Tax % | 36% | 34% | 31% | 34% | 37% | 37% | 15% | 26% | 27% | 26% | 25% | 26% | |
| 4 | 6 | 6 | 6 | 16 | 17 | 19 | 15 | 12 | 21 | 45 | 37 | 33 | |
| EPS in Rs | 0.71 | 1.15 | 1.26 | 1.26 | 3.15 | 3.38 | 3.79 | 3.01 | 2.46 | 4.15 | 9.04 | 7.39 | 6.51 |
| Dividend Payout % | 14% | 9% | 10% | 10% | 6% | 5% | 5% | 6% | 7% | 6% | 3% | 4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | -1% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 14% |
| 3 Years: | 43% |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | 15% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 17 | 22 | 28 | 33 | 48 | 64 | 82 | 96 | 107 | 127 | 171 | 207 | 224 |
| 20 | 20 | 14 | 35 | 30 | 12 | 9 | 4 | 38 | 40 | 12 | 3 | 6 | |
| 24 | 31 | 28 | 30 | 28 | 22 | 31 | 20 | 18 | 20 | 20 | 23 | 21 | |
| Total Liabilities | 66 | 78 | 75 | 103 | 111 | 103 | 127 | 124 | 168 | 193 | 209 | 238 | 256 |
| 34 | 35 | 35 | 35 | 40 | 40 | 46 | 44 | 47 | 49 | 58 | 58 | 56 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 6 | 1 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 45 | 52 |
| 31 | 43 | 41 | 68 | 70 | 63 | 81 | 77 | 115 | 138 | 139 | 135 | 147 | |
| Total Assets | 66 | 78 | 75 | 103 | 111 | 103 | 127 | 124 | 168 | 193 | 209 | 238 | 256 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 6 | 12 | -18 | 17 | 24 | 13 | 9 | -11 | 20 | 50 | 32 | |
| 0 | -1 | -1 | -1 | -5 | -3 | -6 | 1 | -20 | -3 | -29 | -29 | |
| -5 | -5 | -11 | 18 | -11 | -21 | -9 | -7 | 31 | -1 | -30 | -11 | |
| Net Cash Flow | -0 | -0 | 0 | -0 | 1 | 0 | -1 | 3 | 1 | 15 | -10 | -8 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 5 | 8 | 5 | 12 | 10 | 10 | 16 | 5 | 6 | 6 | 11 | 4 |
| Inventory Days | 29 | 36 | 29 | 35 | 33 | 24 | 26 | 22 | 28 | 33 | 30 | 22 |
| Days Payable | 22 | 26 | 18 | 16 | 9 | 9 | 5 | 4 | 4 | 3 | 3 | 3 |
| Cash Conversion Cycle | 12 | 18 | 16 | 32 | 34 | 25 | 37 | 22 | 30 | 35 | 38 | 24 |
| Working Capital Days | -2 | -0 | 3 | 6 | 14 | 19 | 26 | 23 | 24 | 24 | 29 | 24 |
| ROCE % | 27% | 30% | 29% | 24% | 39% | 35% | 27% | 21% | 15% | 20% | 34% | 24% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Feb - Press Release of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended 31st December,2025.
- Regulation 33 Of SEBI (LODR) Regulations, 2015- Submission Of Unaudited Standalone And Consolidated Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended 31St December, 2025. 5 Feb
-
Board Meeting Outcome for Outcome Of The 04/2025-26 Meeting Of Board Held On Thursday, 5Th February, 2026 At The Corporate Office Of The Company As Per Regulation 30 Of SEBI (LODR) Regulations, 2015.
5 Feb - Unaudited standalone & consolidated results approved for quarter and nine months ended 31 Dec 2025; nine-month PAT 2,765.01.
-
Board Meeting Intimation for Holding 04/2025-26 Board Meeting For Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December, 2025.
30 Jan - Board meeting 5 Feb 2026 to approve unaudited results for quarter and nine months ended 31 Dec 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Jan - Certificate of Compliance under Regulation 74(5) of the SEBI (Depository and Participants) Regulation,2018 for the quarter ended on 31st December,2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
KNL is a part of Kriti Group. It is a non-GMO soya-based product manufacturing and processing company. It produces branded refined soya bean oil and value-added protein-based products under the brand Kriti an established name in Central India. The company manufactures soya protein and soya lecithin for downstream industrial users and markets, packages, and brands edible refined oil for its retail consumers.